Psychedelics-based medicine development company Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) (MMED.NE) has come into considerable focus among investors after it was uplisted to NASDAQ recently.
Yesterday, the stock tanked by as much as 75% during the earlier hours of trading but later on in the day, the stock managed to stage a recovery and remained largely flat. While it is true that there was no announcement from the company yesterday, it might be important for investors to take a look at a recent announcement from Mind Medicine.
Last week the company announced that it was launching a new initiative known as Project Angie. The initiative is going to be focused on the possibility of using psychedelic substances likes LSD and others for the treatment of chronic pain. It is necessary to note that Mind Medicine is already working on two products for the purpose of tackling pain. Despite the recent troubles, it is a stock that could be tracked closely by investors.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life